Influence of formulation variables in transdermal drug delivery system containing zolmitriptan

被引:32
|
作者
Subedi, Robhash Kusam [1 ]
Ryoo, Je-Phil
Moon, Cheol
Choi, Hoo-Kyun [1 ]
机构
[1] Chosun Univ, Coll Pharm, Project Team BK21, Kwangju 501759, South Korea
关键词
Zolmitriptan; Transdermal drug delivery; Percutaneous penetration; Chemical enhancers; Polymorphism; Crystallization inhibitor; CRYSTALLIZATION; PERMEATION; ADHESIVES; ENHANCERS; MATRIX; SKIN;
D O I
10.1016/j.ijpharm.2011.08.002
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of different formulation variables including pressure sensitive adhesive (PSA), thickness of the matrix, solvent system, inclusion of crystallization inhibitor, loading amount of drug and enhancers on the transdermal absorption of zolmitriptan were investigated. Acrylic adhesive with hydroxyl functional group provided good adhesion force and high flux of zolmitriptan. Pseudopolymorphs of zolmitriptan were found to possess different solid-state properties that affected the permeation rate. Polyoxyethylene alkyl ethers significantly increased the permeation of zolmitriptan through hairless mouse skin. However, these enhancers induced crystallization of zolmitriptan. Kollidon (R) 30 delayed the crystallization without altering the permeation profile of zolmitriptan. Stability studies suggested that terpenes did not induce crystallization of zolmitriptan in the patch and stable formulations could be produced by using cineole and limonene, or their combination. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:209 / 214
页数:6
相关论文
共 50 条
  • [31] A REVIEW ON TRANSDERMAL DRUG DELIVERY SYSTEM
    Rawat, Ashish
    Bhatt, Ganesh Kumar
    Kothiyal, Preeti
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 3 (05): : 423 - 428
  • [32] Influence of electronic and formulation variables on transdermal iontophoresis of tacrine hydrochloride
    Patel, Niketkumar
    Jain, Shashank
    Madan, Parshotam
    Lin, Senshang
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2015, 20 (04) : 442 - 457
  • [33] FORMULATION ASPECTS ON DERMATOLOGICAL PREPARATIONS AND TRANSDERMAL DRUG DELIVERY SYSTEMS
    JUNGINGER, HE
    ACTA PHARMACEUTICA NORDICA, 1992, 4 (02): : 117 - 117
  • [34] Enhanced transdermal drug delivery of zaltoprofen using a novel formulation
    Baek, Jong-Suep
    Lim, Ji-Ho
    Kang, Jong-Seong
    Shin, Sang-Chul
    Jung, Sang-Hun
    Cho, Cheong-Weon
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 453 (02) : 358 - 362
  • [35] A Novel Binary Supercooled Liquid Formulation for Transdermal Drug Delivery
    Hirakawa, Yuya
    Ueda, Hiroshi
    Wakabayashi, Rie
    Kamiya, Noriho
    Goto, Masahiro
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2020, 43 (03) : 393 - 398
  • [36] Effect of formulation variables on the floating properties of gastric floating drug delivery system
    Li, SF
    Lin, SS
    Daggy, BP
    Mirchandani, HL
    Chien, YW
    DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2002, 28 (07) : 783 - 793
  • [37] Formulation and Evaluation of Bisoprolol Hemifumarate Emulgel for Transdermal Drug Delivery
    Gul, Rahman
    Khan, Yasmin
    Aman, Tajala
    DISSOLUTION TECHNOLOGIES, 2022, 29 (01): : 38 - 44
  • [38] Formulation Development and evaluation of Liposomal Drug Delivery System Containing Etoposide
    Ajay, Fugate
    Shivappa, N. Nagoba
    Hyam, S. R.
    JOURNAL OF COMPLEMENTARY MEDICINE RESEARCH, 2021, 12 (04): : 7 - 20
  • [39] Formulation and in vitro evaluation of pentazocine transdermal delivery system
    Furuishi, Takayuki
    Io, Takeshi
    Fukami, Toshiro
    Suzuki, Toyofumi
    Tomono, Kazuo
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (07) : 1439 - 1443
  • [40] Niosomes: A Promising Drug Delivery System in Transdermal Drug Delivery (TDDS)
    Chatur, Vibhavari M.
    Dhole, Shashikant N.
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (48B) : 6 - 17